Qiagen (QGEN) News Today → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free QGEN Stock Alerts $45.69 -0.30 (-0.65%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16 at 10:03 AM | msn.comHere's Why Investors Should Retain QIAGEN (QGEN) Stock NowMay 15, 2024 | marketbeat.comJump Financial LLC Makes New $1.82 Million Investment in Qiagen (NYSE:QGEN)Jump Financial LLC bought a new stake in Qiagen (NYSE:QGEN - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 41,966 shares of the company's stock, valued at approximately $1,823,000. Other instMay 14, 2024 | globenewswire.comQIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical device software for clinical decision supportMay 13, 2024 | marketbeat.comMassachusetts Financial Services Co. MA Boosts Stock Position in Qiagen (NYSE:QGEN)Massachusetts Financial Services Co. MA lifted its position in Qiagen (NYSE:QGEN - Free Report) by 8.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 24,066,569 shares of the company's stock after purchasingMay 13, 2024 | markets.businessinsider.comFDA Clears Qiagen's QIAstat-Dx Respiratory Syndromic Testing PanelMay 13, 2024 | globenewswire.comQIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accurate resultsMay 12, 2024 | marketbeat.com1,093,234 Shares in Qiagen (NYSE:QGEN) Acquired by Nuance Investments LLCNuance Investments LLC purchased a new stake in Qiagen (NYSE:QGEN - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 1,093,234 shares of the company's stock, valued at approximately $May 11, 2024 | marketbeat.comBNP Paribas Financial Markets Decreases Stake in Qiagen (NYSE:QGEN)BNP Paribas Financial Markets lowered its position in shares of Qiagen (NYSE:QGEN - Free Report) by 7.6% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 1,534,023 shares of the company's stock after selling 126,756 shares during the quarter. BNP Paribas FMay 7, 2024 | msn.comQIAGEN to collaborate with FBI on forensic PCR testMay 7, 2024 | globenewswire.comQIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensicsMay 6, 2024 | marketbeat.comQiagen (NYSE:QGEN) Sees Unusually-High Trading VolumeQiagen (NYSE:QGEN) Sees Strong Trading VolumeMay 5, 2024 | marketbeat.comQiagen (NYSE:QGEN) Holdings Raised by Natixis Advisors L.P.Natixis Advisors L.P. increased its position in shares of Qiagen (NYSE:QGEN - Free Report) by 101.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 598,279 shares of the company's stock after purchasing an additionalMay 4, 2024 | marketbeat.comVan ECK Associates Corp Sells 21,264 Shares of Qiagen (NYSE:QGEN)Van ECK Associates Corp decreased its position in shares of Qiagen (NYSE:QGEN - Free Report) by 9.5% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 202,226 shares of the company's stock after selling 21,264 sMay 3, 2024 | marketbeat.comWilliam Blair Weighs in on Qiagen's Q4 2025 Earnings (NYSE:QGEN)Qiagen (NYSE:QGEN - Free Report) - Investment analysts at William Blair raised their Q4 2025 earnings per share estimates for shares of Qiagen in a research note issued on Wednesday, May 1st. William Blair analyst A. Brackmann now expects that the company will earn $0.62 per share for the quarterMay 2, 2024 | markets.businessinsider.comCellectis CFO Bing Wang Resigns; Appoints Arthur Stril As Interim CFOMay 2, 2024 | marketbeat.comBank of Italy Buys 196,756 Shares of Qiagen (NYSE:QGEN)Bank of Italy increased its stake in shares of Qiagen (NYSE:QGEN - Free Report) by 30.2% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 847,881 shares of the company's stock after acquiring an additional 196,756 shares during the period.May 2, 2024 | globenewswire.comQIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applicationsMay 2, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Qiagen (QGEN), Inari Medical (NARI)May 2, 2024 | finance.yahoo.comQiagen N.V. Just Recorded A 6.9% EPS Beat: Here's What Analysts Are Forecasting NextMay 1, 2024 | finance.yahoo.comQiagen N.V. (NYSE:QGEN) Q1 2024 Earnings Call TranscriptMay 1, 2024 | marketbeat.comAnalysts Issue Forecasts for Qiagen's Q3 2025 Earnings (NYSE:QGEN)Qiagen (NYSE:QGEN - Free Report) - Equities research analysts at Zacks Research lowered their Q3 2025 earnings per share (EPS) estimates for shares of Qiagen in a research note issued to investors on Monday, April 29th. Zacks Research analyst M. Mondal now expects that the company will earn $0.55May 1, 2024 | finance.yahoo.comQiagen First Quarter 2024 Earnings: EPS Beats ExpectationsApril 30, 2024 | marketbeat.com55,000 Shares in Qiagen (NYSE:QGEN) Acquired by Sivik Global Healthcare LLCSivik Global Healthcare LLC acquired a new stake in Qiagen (NYSE:QGEN - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 55,000 shares of the company's stock, valued at approximately $2,389,000. Other large investorsApril 30, 2024 | seekingalpha.comQiagen N.V. 2024 Q1 - Results - Earnings Call PresentationApril 30, 2024 | finanznachrichten.deQIAGEN N.V.: QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidanceApril 30, 2024 | marketbeat.comQiagen (NYSE:QGEN) Posts Earnings Results, Beats Estimates By $0.02 EPSQiagen (NYSE:QGEN - Get Free Report) issued its earnings results on Monday. The company reported $0.46 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.44 by $0.02. The business had revenue of $459.00 million for the quarter, compared to analyst estimates of $453.91 million. Qiagen had a net margin of 17.37% and a return on equity of 12.99%. The company's revenue for the quarter was down 5.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.53 EPS.April 30, 2024 | marketbeat.comQ2 2024 EPS Estimates for Qiagen (NYSE:QGEN) Decreased by AnalystQiagen (NYSE:QGEN - Free Report) - Analysts at Zacks Research decreased their Q2 2024 earnings per share (EPS) estimates for Qiagen in a research report issued on Monday, April 29th. Zacks Research analyst M. Mondal now anticipates that the company will post earnings per share of $0.51 for the quApril 29, 2024 | msn.comQGEN Stock Earnings: Qiagen Beats EPS, Beats Revenue for Q1 2024April 29, 2024 | marketbeat.comQiagen (NYSE:QGEN) Releases FY 2024 Earnings GuidanceQiagen (NYSE:QGEN) updated its FY 2024 earnings guidance. The company provided EPS guidance of 2.100- for the period, compared to the consensus estimate of 2.110. The company also issued revenue guidance of $2.0 billionillion-, compared to the consensus estimate of $2.0 billionillion.April 29, 2024 | globenewswire.comQIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidanceApril 28, 2024 | msn.comQiagen Q1 2024 Earnings PreviewApril 26, 2024 | finance.yahoo.com7 Best Sites Like Ancestry.com to Research Your Family HistoryApril 25, 2024 | finanznachrichten.deQIAGEN N.V.: QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistanceApril 24, 2024 | globenewswire.comQIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistanceApril 17, 2024 | markets.businessinsider.comBank of America Securities Reaffirms Their Buy Rating on Qiagen (QGEN)April 9, 2024 | globenewswire.comQIAGEN N.V. to release results for Q1 2024 and hold webcastApril 9, 2024 | marketbeat.comQiagen (NYSE:QGEN) Given Average Recommendation of "Moderate Buy" by AnalystsShares of Qiagen (NYSE:QGEN - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the eight brokerages that are presently covering the company, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and five have given a buyApril 4, 2024 | finanznachrichten.deQIAGEN N.V.: QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024April 3, 2024 | globenewswire.comQIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024April 3, 2024 | marketbeat.comQiagen (NYSE:QGEN) Shares Gap Down to $42.21Qiagen (NYSE:QGEN) Shares Gap Down to $42.21March 27, 2024 | nasdaq.comQGEN Makes Notable Cross Below Critical Moving AverageMarch 27, 2024 | businesswire.comMyBio Are the New Exclusive Partner for QIAGEN in Ireland & Northern IrelandMarch 26, 2024 | finanznachrichten.deQIAGEN N.V.: QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare systemMarch 25, 2024 | globenewswire.comQIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare systemMarch 21, 2024 | finance.yahoo.comHas Qiagen N.V. (NYSE:QGEN) Stock's Recent Performance Got Anything to Do With Its Financial Health?March 19, 2024 | finanznachrichten.deQIAGEN N.V.: QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosis screening requirementsMarch 18, 2024 | globenewswire.comQIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosis screening requirementsMarch 16, 2024 | ca.finance.yahoo.comQGEN Apr 2024 60.000 callMarch 15, 2024 | marketbeat.comQiagen (NYSE:QGEN) Given Average Rating of "Moderate Buy" by AnalystsQiagen (NYSE:QGEN - Get Free Report) has earned an average recommendation of "Moderate Buy" from the eight brokerages that are presently covering the firm, Marketbeat.com reports. Three analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the companyMarch 11, 2024 | globenewswire.comQIAGEN announces Form 20-F annual report filing for 2023 results Get Qiagen News Delivered to You Automatically Sign up to receive the latest news and ratings for QGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. QGEN Media Mentions By Week QGEN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. QGEN News Sentiment▼0.800.42▲Average Medical News Sentiment QGEN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. QGEN Articles This Week▼75▲QGEN Articles Average Week Get Qiagen News Delivered to You Automatically Sign up to receive the latest news and ratings for QGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: RGEN News TECH News PCVX News RVMD News EXEL News IBRX News HALO News NBIX News CRSP News KRYS News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:QGEN) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Qiagen Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.